Cannabinoid Encyclopedia

Focused research review

How does CBC affect memory, mood, and thinking?

What evidence connects CBC with neurobehavioral, mood, neural stem cell, or neurogenesis outcomes?

Updated July 2026 12 research sources Mostly early-stage research

The short answer

What is the bottom line?

Research has examined CBC and memory, mood, and thinking. This page brings together 3 human-study sources, 3 research reviews, and 6 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about CBC and memory, mood, and thinking.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on CBC and memory, mood, and thinking covers Neurobehavioral, mood, neural stem cell, or neurogenesis outcomes; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about CBC and memory, mood, and thinking

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

Neurobehavioral, mood, neural stem cell, or neurogenesis outcomes

This part of the literature focuses on Neurobehavioral, mood, neural stem cell, or neurogenesis outcomes. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

3 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

3 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

6 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on CBC and memory, mood, and thinking is not one kind of study. This source set includes 6 animal studies, 3 narrative or expert reviews, and 2 cell or laboratory studies. 3

The recorded populations or models include people or patients (4 sources), animal models (3 sources), and cells or tissue models (3 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is neurobehavioral, mood, neural stem cell, or neurogenesis outcomes (12 sources). Closely related outcome names can still describe different measurements. 5

The CBC and memory, mood, and thinking source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

Antidepressant Effects of South African Plants: An Appraisal of Ethnobotanical Surveys, Ethnopharmacological and Phytochemical Studies.

On this page, this source examines CBC and neurobehavioral, mood, neural stem cell, or neurogenesis outcomes. 1

Study type
narrative or expert review
Population or model
cells or tissue models
Outcome focus
neurobehavioral, mood, neural stem cell, or neurogenesis outcomes
Evidence stage
evidence still limited

animal study

Anti-inflammatory and analgesic potential of minor cannabinoids in vivo.

On this page, this source examines CBC and neurobehavioral, mood, neural stem cell, or neurogenesis outcomes. 2

Study type
animal study
Population or model
people or patients
Outcome focus
neurobehavioral, mood, neural stem cell, or neurogenesis outcomes
Evidence stage
mechanism-focused research

evidence still limited

Enhancing Cannabichromenic Acid Biosynthesis in Saccharomyces cerevisiae.

On this page, this source examines CBC and neurobehavioral, mood, neural stem cell, or neurogenesis outcomes. 3

Outcome focus
neurobehavioral, mood, neural stem cell, or neurogenesis outcomes
Evidence stage
evidence still limited

animal study

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

On this page, this source examines CBC and neurobehavioral, mood, neural stem cell, or neurogenesis outcomes. 4

Study type
animal study
Population or model
animal models
Outcome focus
neurobehavioral, mood, neural stem cell, or neurogenesis outcomes
Evidence stage
preclinical research

narrative or expert review

Cannabigerol and cannabichromene in Cannabis sativa L.

On this page, this source examines CBC and neurobehavioral, mood, neural stem cell, or neurogenesis outcomes. 5

Study type
narrative or expert review
Population or model
people or patients
Outcome focus
neurobehavioral, mood, neural stem cell, or neurogenesis outcomes
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

Research on CBC and memory, mood, and thinking should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence connects CBC with neurobehavioral, mood, neural stem cell, or neurogenesis outcomes?

Relevant research is collected here. Most of the current evidence is preclinical or focused on biological mechanisms. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Antidepressant Effects of South African Plants: An Appraisal of Ethnobotanical Surveys, Ethnopharmacological and Phytochemical Studies. narrative or expert review; evidence still limited PubMed 35846999 DOI 10.3389/fphar.2022.895286
  2. 2
    Anti-inflammatory and analgesic potential of minor cannabinoids in vivo. animal study; mechanism-focused research PubMed 41680865 DOI 10.1186/s42238-025-00384-7
  3. 3
    Enhancing Cannabichromenic Acid Biosynthesis in Saccharomyces cerevisiae. evidence still limited PubMed 39808700 DOI 10.1021/acssynbio.4c00721
  4. 4
    Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. animal study; preclinical research PubMed 20332000 DOI 10.1016/j.pbb.2010.03.004
  5. 5
    Cannabigerol and cannabichromene in Cannabis sativa L. narrative or expert review; evidence still limited PubMed 36654096 DOI 10.2478/acph-2021-0021
  6. 6
    Under the umbrella of depression and Alzheimer's disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy? narrative or expert review; evidence still limited PubMed 37414155 DOI 10.1016/j.arr.2023.101998
  7. 7
    Cannabichromene as a Novel Inhibitor of Th2 Cytokine and JAK/STAT Pathway Activation in Atopic Dermatitis Models. animal study; mechanism-focused research PubMed 39769302 DOI 10.3390/ijms252413539
  8. 8
    Cannabichromene, a key non-psychotropic phytocannabinoid in treatment of major depressive disorder: in silico and in vivo explorations. animal study; mechanism-focused research PubMed 40358684 DOI 10.1007/s00210-025-04236-2
  9. 9
    The effect of cannabichromene on adult neural stem/progenitor cells. animal study; mechanism-focused research PubMed 23941747 DOI 10.1016/j.neuint.2013.08.002
  10. 10
    Therapeutic potential of phytocannabinoids in depression and cognitive dysfunction: Evidence from preclinical models. animal study; mechanism-focused research PubMed 41934896 DOI 10.1016/j.biopha.2026.119298
  11. 11
    Cannabichromene Induces Neuronal Differentiation in NSC-34 Cells: Insights from Transcriptomic Analysis. cell or laboratory study; mechanism-focused research PubMed 36983897 DOI 10.3390/life13030742
  12. 12
    In vitro evaluation of the interaction of the cannabis constituents cannabichromene and cannabichromenic acid with ABCG2 and ABCB1 transporters. cell or laboratory study; evidence still limited PubMed 35306000 DOI 10.1016/j.ejphar.2022.174836
See all 12 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Anti-inflammatory and analgesic potential of minor cannabinoids in vivo. animal study; mechanism-focused research / 1 linked research note PubMed 41680865
  2. Enhancing Cannabichromenic Acid Biosynthesis in Saccharomyces cerevisiae. evidence still limited / 1 linked research note PubMed 39808700
  3. In vitro evaluation of the interaction of the cannabis constituents cannabichromene and cannabichromenic acid with ABCG2 and ABCB1 transporters. cell or laboratory study; evidence still limited / 1 linked research note PubMed 35306000
  4. Under the umbrella of depression and Alzheimer's disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy? narrative or expert review; evidence still limited / 1 linked research note PubMed 37414155
  5. Therapeutic potential of phytocannabinoids in depression and cognitive dysfunction: Evidence from preclinical models. animal study; mechanism-focused research / 1 linked research note PubMed 41934896
  6. Cannabigerol and cannabichromene in Cannabis sativa L. narrative or expert review; evidence still limited / 1 linked research note PubMed 36654096
  7. Cannabichromene as a Novel Inhibitor of Th2 Cytokine and JAK/STAT Pathway Activation in Atopic Dermatitis Models. animal study; mechanism-focused research / 1 linked research note PubMed 39769302
  8. Cannabichromene Induces Neuronal Differentiation in NSC-34 Cells: Insights from Transcriptomic Analysis. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 36983897
  9. Antidepressant Effects of South African Plants: An Appraisal of Ethnobotanical Surveys, Ethnopharmacological and Phytochemical Studies. narrative or expert review; evidence still limited / 1 linked research note PubMed 35846999
  10. Cannabichromene, a key non-psychotropic phytocannabinoid in treatment of major depressive disorder: in silico and in vivo explorations. animal study; mechanism-focused research / 1 linked research note PubMed 40358684
  11. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. animal study; preclinical research / 1 linked research note PubMed 20332000
  12. The effect of cannabichromene on adult neural stem/progenitor cells. animal study; mechanism-focused research / 1 linked research note PubMed 23941747